日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol

过敏反应后维持奥沙利铂治疗:脱敏方案的真实世界经验

Christodoulis, Eleftherios; Vlachostergios, Panagiotis J; Connell, Jacqueline; Williams, Joseph; Hasan, Jurjees; Mansoor, Wasat; Mullamitha, Saifee; Hubner, Richard A; Braun, Michael; Saunders, Mark P; Marti Marti, Francisca; Angelakas, Angelos; Waddell, Tom; Alam, Nooreen; Kamposioras, Konstantinos

Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK

英国食管胃癌诊疗最佳检测路径改良德尔菲共识的结果

Rodriguez-Justo, Manuel; Mansoor, Wasat; Bird, Thomas; Eatock, Martin; Starling, Naureen; Taniere, Philippe

First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study

一线纳武利尤单抗和瑞拉利单抗联合化疗治疗胃或胃食管交界处腺癌:II期RELATIVITY-060研究

Hegewisch-Becker, Susanna; Mendez, Guillermo; Chao, Joseph; Nemecek, Radim; Feeney, Kynan; Van Cutsem, Eric; Al-Batran, Salah-Eddin; Mansoor, Wasat; Maisey, Nicholas; Pazo Cid, Roberto; Burge, Matthew; Perez-Callejo, David; Hipkin, R William; Mukherjee, Sourav; Lei, Ming; Tang, Hao; Suryawanshi, Satyendra; Kelly, Ronan J; Tebbutt, Niall C

Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer

KEYNOTE-590研究中与健康相关的生活质量分析:帕博利珠单抗联合化疗与单纯化疗治疗晚期食管癌

Mansoor, Wasat; Joo, Seongjung; Norquist, Josephine M; Kato, Ken; Sun, Jong-Mu; Shah, Manish A; Enzinger, Peter; Adenis, Antoine; Doi, Toshihiko; Kojima, Takashi; Metges, Jean-Philippe; Li, Zhigang; Kim, Sung-Bae; Cho, Byoung Chol; Sunpaweravong, Patrapim; Alsina, Maria; Goekkurt, Eray; Suryawanshi, Shailaja; Shah, Sukrut; Shen, Lin

Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

基因表达特征与帕博利珠单抗对比紫杉醇治疗晚期胃癌的临床疗效之间的关联:来自随机、对照、III期KEYNOTE-061试验的探索性分析

Shitara, Kohei; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Caglevic, Christian; Olesinski, Tomasz; Chung, Hyun Cheol; Muro, Kei; Goekkurt, Eray; McDermott, Raymond S; Mansoor, Wasat; Wainberg, Zev A; Shih, Chie-Schin; Kobie, Julie; Nebozhyn, Michael; Cristescu, Razvan; Cao, Z Alexander; Loboda, Andrey; Özgüroğlu, Mustafa

NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

NET-02:一项随机、非对照的II期临床试验,旨在评估nal-IRI/5-FU或多西他赛作为二线疗法治疗进展性低分化肺外神经内分泌癌患者的疗效。

McNamara, Mairéad G; Swain, Jayne; Craig, Zoe; Sharma, Rohini; Faluyi, Olusola; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R; Chau, Ian; Reed, Nick; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sothi, Sharmila; Anthoney, Alan; Bell, Christopher; Patel, Alkesh; Oughton, Jamie B; Cairns, David A; Mansoor, Wasat; Lamarca, Angela; Hubner, Richard A; Valle, Juan W

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

用于预测接受一线曲妥珠单抗治疗的晚期 HER2 阳性食管胃腺癌患者生存期的 AGAMENON-SEOM 模型

Jimenez-Fonseca, Paula; Foy, Victoria; Raby, Sophie; Carmona-Bayonas, Alberto; Macía-Rivas, Lola; Arrazubi, Virginia; Cacho Lavin, Diego; Hernandez San Gil, Raquel; Custodio, Ana; Cano, Juana María; Fernández Montes, Ana; Mirallas, Oriol; Macias Declara, Ismael; Vidal Tocino, Rosario; Visa, Laura; Limón, María Luisa; Pimentel, Paola; Martínez Lago, Nieves; Sauri, Tamara; Martín Richard, Marta; Mangas, Monserrat; Gil Raga, Mireia; Calvo, Aitana; Reguera, Pablo; Granja, Mónica; Martín Carnicero, Alfonso; Hernández Pérez, Carolina; Cerdá, Paula; Gomez Gonzalez, Lucía; Garcia Navalon, Francisco; Pacheco Barcia, Vilma; Gutierrez Abad, David; Ruiz Martín, Maribel; Weaver, Jamie; Mansoor, Wasat; Gallego, Javier

AB006. Effectiveness of chemotherapy as the first-line treatment for thymic tumors with pleural dissemination

AB006. 化疗作为胸膜播散性胸腺肿瘤一线治疗的疗效

Cunningham, David; Stenning, Sally P; Smyth, Elizabeth C; Okines, Alicia F; Allum, William H; Rowley, Sam; Stevenson, Laura; Grabsch, Heike I; Alderson, Derek; Crosby, Thomas; Griffin, S Michael; Mansoor, Wasat; Coxon, Fareeda Y; Falk, Stephen J; Darby, Suzanne; Sumpter, Kate A; Blazeby, Jane M; Langley, Ruth E; Zhang, Xuefei; Gao, Lanting; Hao, Xiuxiu; Yu, Fenghao; Gu, Zhitao; Fang, Wentao

T-Cell Infiltration and Clonality May Identify Distinct Survival Groups in Colorectal Cancer: Development and Validation of a Prognostic Model Based on The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC)

T细胞浸润和克隆性可能识别结直肠癌中不同的生存组:基于癌症基因组图谱(TCGA)和临床蛋白质组肿瘤分析联盟(CPTAC)的预后模型的开发和验证

Campana, Luca G; Mansoor, Wasat; Hill, James; Macutkiewicz, Christian; Curran, Finlay; Donnelly, David; Hornung, Ben; Charleston, Peter; Bristow, Robert; Lord, Graham M; Valpione, Sara

Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter

对于直径小于10毫米的I型胃神经内分泌肿瘤,单独进行内镜监测是可行且安全的。

Exarchou, Klaire; Hu, Haiyi; Stephens, Nathan A; Moore, Andrew R; Kelly, Mark; Lamarca, Angela; Mansoor, Wasat; Hubner, Richard; McNamara, Mairéad G; Smart, Howard; Howes, Nathan R; Valle, Juan W; Pritchard, D Mark